Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
23 26 Search
2024
Resistance to Anti-CD20 Antibodies and Approaches for Their Reversal
2023
What is new about primary cutaneous B cell lymphomas
Italian Journal of Dermatology and Venereology
2023
Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy
Cells
2023
Narrative Review of Anti-CD3 Antibody and Anti-CD20 Antibody: Immunotherapeutic Strategies to Treat and Prevent Type 1 Diabetes
Recent Advances in Inflammation & Allergy Drug Discovery
2023
Multi-targeted immunotherapeutics to treat B cell malignancies
Journal of Controlled Release
2023
Effective clearance of rituximab-resistant tumor cells by breaking the mirror-symmetry of immunoglobulin G and simultaneous binding to CD55 and CD20
Scientific Reports
2022
Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy
Scientific Reports
2022
Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo
Journal of Controlled Release
2021
Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis
Science Advances
2021
Cancer Immunology
2020
Comparative Transcriptome Analysis of the Heat Stress Response in Monochamus alternatus Hope (Coleoptera: Cerambycidae)
Frontiers in Physiology
2018
Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistance
The Pharmacogenomics Journal
2018
Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
Frontiers in Oncology
2015
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes
International Journal of Cancer
2015
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
Experimental Hematology & Oncology
2015
Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma
Journal of Immunotherapy
2015
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results
Biology of Blood and Marrow Transplantation
2015
Cancer Immunology
2015
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review
Molecular Cancer
2014
Update on obinutuzumab in the treatment of B-cell malignancies
Expert Opinion on Biological Therapy
2014
Postulated Mechanisms of Resistance of B-Cell Non-Hodgkin Lymphoma to Rituximab Treatment Regimens: Strategies to Overcome Resistance
Seminars in Oncology
Additional cited-by details will be shown when available from Crossref